Search research articles
Contact Us
Filters
Showing results (141-150 of 145) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 145 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 29, 2025
Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study
Özgür Yaldizli, Pascal Benkert, Lutz Achtnichts, et al.
Annals of Neurology
|
July 6, 2026
Assessing Progression Independent of Relapse Activity in Multiple Sclerosis Using a Patient-Reported Disability Measure and Self-Administered Neuroperformance Outcomes
Evy M Reinders, Ariadna Masot-Llima, Susana Otero-Romero, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 27, 2022
Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?
Ana Zabalza, Georgina Arrambide, Susana Otero-Romero, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 24, 2022
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021
Carmen Tur, Anne-Laure Dubessy, Susana Otero-Romero, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 24, 2026
Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progression
Alvaro Cobo-Calvo, Juan Pablo Cuello, Enric Monreal, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 145) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 145 results.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 29, 2025
Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi Study
Özgür Yaldizli, Pascal Benkert, Lutz Achtnichts, et al.
Annals of Neurology
|
July 6, 2026
Assessing Progression Independent of Relapse Activity in Multiple Sclerosis Using a Patient-Reported Disability Measure and Self-Administered Neuroperformance Outcomes
Evy M Reinders, Ariadna Masot-Llima, Susana Otero-Romero, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
April 27, 2022
Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?
Ana Zabalza, Georgina Arrambide, Susana Otero-Romero, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 24, 2022
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021
Carmen Tur, Anne-Laure Dubessy, Susana Otero-Romero, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
June 24, 2026
Chronological ageing and ovarian reserve in MS: insights from anti-Müllerian hormone and disability progression
Alvaro Cobo-Calvo, Juan Pablo Cuello, Enric Monreal, et al.
Page
of 15